SBFM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Sunshine Biopharma Inc

NASDAQ | SBFM

2.13

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$8.79M

Market Cap

-

P/E Ratio

-15.02

EPS

$3.59

52 Week High

$1.16

52 Week Low

HEALTHCARE

Sector

SBFM Chart

Recent Chart
Price Action

SBFM Technicals

Tags:

SBFM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $35M
Cost Of Revenue $24M
Costof Goods And Services Sold $24M
Operating Income -$5.8M
Selling General And Administrative $14M
Research And Development $934K
Operating Expenses $16M
Investment Income Net -
Net Interest Income $487K
Interest Income $496K
Interest Expense $8.8K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $224K
Income Before Tax -$5.4M
Income Tax Expense -$235K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.1M
Comprehensive Income Net Of Tax -
Ebit -$5.4M
Ebitda -$5.2M
Net Income -$5.1M

Revenue & Profitability

Earnings Performance

SBFM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $31M
Total Current Assets $26M
Cash And Cash Equivalents At Carrying Value $9.7M
Cash And Short Term Investments $9.7M
Inventory $11M
Current Net Receivables $3.9M
Total Non Current Assets $4.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $3M
Intangible Assets Excluding Goodwill $3M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.1M
Other Non Current Assets -
Total Liabilities $7.1M
Total Current Liabilities $6.3M
Current Accounts Payable $5.5M
Deferred Revenue -
Current Debt -
Short Term Debt $208K
Total Non Current Liabilities $745K
Capital Lease Obligations $952K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $952K
Other Current Liabilities $296K
Other Non Current Liabilities -
Total Shareholder Equity $24M
Treasury Stock -
Retained Earnings -$69M
Common Stock $2.6K
Common Stock Shares Outstanding $702K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$13M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $224K
Capital Expenditures $2.3M
Change In Receivables -
Change In Inventory -$6M
Profit Loss -
Cashflow From Investment -$2.3M
Cashflow From Financing $9.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$3.1M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.1M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $35M
Cost Of Revenue $24M
Costof Goods And Services Sold $24M
Operating Income -$5.8M
Selling General And Administrative $14M
Research And Development $934K
Operating Expenses $16M
Investment Income Net -
Net Interest Income $487K
Interest Income $496K
Interest Expense $8.8K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $224K
Income Before Tax -$5.4M
Income Tax Expense -$235K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.1M
Comprehensive Income Net Of Tax -
Ebit -$5.4M
Ebitda -$5.2M
Net Income -$5.1M

SBFM News

SBFM Profile

Sunshine Biopharma Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Sunshine Biopharma Inc. is a Canadian pharmaceutical company dedicated to the development and commercialization of innovative anticancer therapeutics. Based in Pointe-Claire, Quebec, the company is committed to addressing unmet medical needs in oncology through its proprietary drug candidates, which leverage cutting-edge science and research. With a robust pipeline aimed at delivering effective treatments for various forms of cancer, Sunshine Biopharma is positioned to make significant contributions to the field and enhance patient outcomes in oncology care.

VHAI
-20.00%
$0.00
VIVK
-0.33%
$0.29
BURU
+6.18%
$0.35
YYAI
-0.81%
$0.13
CGBS
-39.47%
$0.03
EPWK
+29.85%
$0.09
ADAP
+15.15%
$0.21
BITF
-15.91%
$5.44
PLUG
-3.48%
$3.71
MIRA
+57.57%
$2.08
NVDA
+0.32%
$180.42
NIO
-0.43%
$6.79
RGTI
-14.02%
$48.44
WHWK
+19.04%
$2.50
BYND
-11.93%
$0.59
NVTS
+2.37%
$15.52
RXRX
-4.19%
$6.50
DNN
-1.05%
$3.13
YDKG
-34.05%
$0.12
AXDX
-61.36%
$0.03
F
-0.72%
$11.67
TLRY
-6.65%
$1.56
IONZ
+18.79%
$3.42
VSEE
-17.98%
$0.49
BBD
+2.04%
$3.26
CAN
-15.05%
$1.66
LGCB
+27.38%
$2.10
DFLI
-31.03%
$1.35
ONDS
-14.10%
$8.16
INTC
-1.17%
$36.71
ACHR
-5.54%
$12.30
MASK
+19.07%
$0.58
LAES
-13.08%
$6.50
BTG
+2.77%
$5.82
AAL
-5.45%
$11.81
RMBL
+60.50%
$3.21
HPE
-11.08%
$22.26
AMD
-0.71%
$236.89
ADD
-25.47%
$0.05
GNPX
-37.33%
$0.52
QBTS
-10.16%
$40.23
AUUD
+10.24%
$2.25
NEHC
+9.12%
$3.35
CRML
-6.33%
$21.28
SRM
+53.27%
$10.30
GDXD
-10.51%
$0.59
QSI
-2.43%
$2.56
KDLY
+1.29%
$0.79
ABAT
-32.91%
$6.00
SOFI
-4.78%
$26.69
CLF
-1.61%
$13.72
ETHD
+4.49%
$3.95
WOK
+1.21%
$0.05
TSLA
-0.53%
$432.82
RGTZ
+28.73%
$11.20
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
IREN
-7.13%
$63.12
TOVX
-43.45%
$0.47
RIG
-1.81%
$3.25
QS
-9.15%
$16.21
MARA
-7.70%
$21.08
NAK
-15.15%
$2.24
WLGS
-5.57%
$0.04
CIFR
-9.12%
$19.11
GPUS
-4.25%
$0.36
SMR
-7.31%
$49.52
ETWO
0.00%
$3.30
SLNH
+2.09%
$4.38
QUBT
-9.06%
$19.30
CLSK
-11.58%
$20.51
SBFM
+10.72%
$2.13
SOUN
-3.87%
$20.57
ELWS
+74.72%
$6.43
UUUU
-7.22%
$23.18
SNAP
-2.29%
$7.72
APLD
+0.05%
$37.78
MU
+5.84%
$203.16
RR
-6.24%
$5.77
SOND
+47.30%
$1.35
AFMD
-34.94%
$0.18
WULF
-8.14%
$14.21
PLTR
-0.60%
$178.53
RYOJ
+77.41%
$3.85
ASST
-11.49%
$0.84
DVLT
-11.19%
$1.86
WTO
-87.68%
$0.14
BTBT
-6.77%
$3.78
KEY
-4.43%
$16.94
TMQ
-11.44%
$7.49
ELBM
-25.10%
$1.73
RF
-2.92%
$24.01
EOSE
-12.91%
$15.92
OPI
-16.97%
$0.20
HBAN
-3.45%
$15.65
GRAB
-3.03%
$5.74
BTE
+1.73%
$2.35
IONQ
-8.99%
$65.89
KLG
-9.05%
$13.35
BMNR
-2.88%
$52.25
VHAI
-20.00%
$0.00
VIVK
-0.33%
$0.29
BURU
+6.18%
$0.35
YYAI
-0.81%
$0.13
CGBS
-39.47%
$0.03
EPWK
+29.85%
$0.09
ADAP
+15.15%
$0.21
BITF
-15.91%
$5.44
PLUG
-3.48%
$3.71
MIRA
+57.57%
$2.08
NVDA
+0.32%
$180.42
NIO
-0.43%
$6.79
RGTI
-14.02%
$48.44
WHWK
+19.04%
$2.50
BYND
-11.93%
$0.59
NVTS
+2.37%
$15.52
RXRX
-4.19%
$6.50
DNN
-1.05%
$3.13
YDKG
-34.05%
$0.12
AXDX
-61.36%
$0.03
F
-0.72%
$11.67
TLRY
-6.65%
$1.56
IONZ
+18.79%
$3.42
VSEE
-17.98%
$0.49
BBD
+2.04%
$3.26
CAN
-15.05%
$1.66
LGCB
+27.38%
$2.10
DFLI
-31.03%
$1.35
ONDS
-14.10%
$8.16
INTC
-1.17%
$36.71
ACHR
-5.54%
$12.30
MASK
+19.07%
$0.58
LAES
-13.08%
$6.50
BTG
+2.77%
$5.82
AAL
-5.45%
$11.81
RMBL
+60.50%
$3.21
HPE
-11.08%
$22.26
AMD
-0.71%
$236.89
ADD
-25.47%
$0.05
GNPX
-37.33%
$0.52
QBTS
-10.16%
$40.23
AUUD
+10.24%
$2.25
NEHC
+9.12%
$3.35
CRML
-6.33%
$21.28
SRM
+53.27%
$10.30
GDXD
-10.51%
$0.59
QSI
-2.43%
$2.56
KDLY
+1.29%
$0.79
ABAT
-32.91%
$6.00
SOFI
-4.78%
$26.69
CLF
-1.61%
$13.72
ETHD
+4.49%
$3.95
WOK
+1.21%
$0.05
TSLA
-0.53%
$432.82
RGTZ
+28.73%
$11.20
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
IREN
-7.13%
$63.12
TOVX
-43.45%
$0.47
RIG
-1.81%
$3.25
QS
-9.15%
$16.21
MARA
-7.70%
$21.08
NAK
-15.15%
$2.24
WLGS
-5.57%
$0.04
CIFR
-9.12%
$19.11
GPUS
-4.25%
$0.36
SMR
-7.31%
$49.52
ETWO
0.00%
$3.30
SLNH
+2.09%
$4.38
QUBT
-9.06%
$19.30
CLSK
-11.58%
$20.51
SBFM
+10.72%
$2.13
SOUN
-3.87%
$20.57
ELWS
+74.72%
$6.43
UUUU
-7.22%
$23.18
SNAP
-2.29%
$7.72
APLD
+0.05%
$37.78
MU
+5.84%
$203.16
RR
-6.24%
$5.77
SOND
+47.30%
$1.35
AFMD
-34.94%
$0.18
WULF
-8.14%
$14.21
PLTR
-0.60%
$178.53
RYOJ
+77.41%
$3.85
ASST
-11.49%
$0.84
DVLT
-11.19%
$1.86
WTO
-87.68%
$0.14
BTBT
-6.77%
$3.78
KEY
-4.43%
$16.94
TMQ
-11.44%
$7.49
ELBM
-25.10%
$1.73
RF
-2.92%
$24.01
EOSE
-12.91%
$15.92
OPI
-16.97%
$0.20
HBAN
-3.45%
$15.65
GRAB
-3.03%
$5.74
BTE
+1.73%
$2.35
IONQ
-8.99%
$65.89
KLG
-9.05%
$13.35
BMNR
-2.88%
$52.25
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.